Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Untreated Advanced NSCLC”

113 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 113 results

Testing effectiveness (Phase 2)Study completedNCT01160744
What this trial is testing

Pemetrexed and Carboplatin/Cisplatin or Gemcitabine and Carboplatin/Cisplatin With or Without IMC-1121B in Participants Previously Untreated With Recurrent or Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Eli Lilly and Company 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT06162572
What this trial is testing

Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Servier Bio-Innovation LLC 102
Early research (Phase 1)Study completedNCT00006036
What this trial is testing

Liposomal Lurtotecan Plus Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck CancerLung CancerOvarian Cancer+1 more
NCIC Clinical Trials Group 14
Testing effectiveness (Phase 2)Active Not RecruitingNCT05565378
What this trial is testing

A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

Who this might be right for
Lung Cancer, Non-Small Cell
GlaxoSmithKline 351
Testing effectiveness (Phase 2)Looking for participantsNCT07117890
What this trial is testing

Sunvozertinib Treatment in Untreated Advanced NSCLC With EGFR Uncommon Mutations

Who this might be right for
Non Small Cell Lung Cancer
Fudan University 34
Early research (Phase 1)Study completedNCT00002519
What this trial is testing

Paclitaxel Plus Radiation Therapy in Treating Patients With Untreated Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Looking for participantsNCT04105270
What this trial is testing

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Who this might be right for
Adenocarcinoma of LungLung Cancer
Masonic Cancer Center, University of Minnesota 82
Large-scale testing (Phase 3)Study completedNCT00752115
What this trial is testing

Combination Chemotherapy With Sildenafil Plus Carboplatin and Paclitaxel in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Hamamatsu University 120
Testing effectiveness (Phase 2)Study completedNCT01945021
What this trial is testing

Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC

Who this might be right for
Non Small Cell Lung CancerROS1 Proto OncogeneCrizotinib
Pfizer 129
Testing effectiveness (Phase 2)Ended earlyNCT05469178
What this trial is testing

A Clinical Study of Bemcentinib With Standard of Care Chemoimmunotherapy in Untreated Advanced/Metastatic Non-small Cell Lung Cancer Patients With a Mutation in the STK11 Gene

Who this might be right for
Carcinoma, Non-Small-Cell Lung
BerGenBio ASA 26
Not applicableEnded earlyNCT00904514
What this trial is testing

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 241
Testing effectiveness (Phase 2)Study completedNCT00016367
What this trial is testing

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT00881296
What this trial is testing

Gemcitabine and Carboplatin for Elderly Patient With Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Hamamatsu University 60
Large-scale testing (Phase 3)Not Yet RecruitingNCT07816380
What this trial is testing

A Phase III Study to Evaluate the Efficacy and Safety of JYP0322 in Previously Untreated ROS1-Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Guangzhou JOYO Pharma Co., Ltd 216
Testing effectiveness (Phase 2)Study completedNCT01493843
What this trial is testing

Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
Genentech, Inc. 501
Not applicableStudy completedNCT02245100
What this trial is testing

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage IIIA Non-small Cell Lung Cancer+27 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 130
Large-scale testing (Phase 3)Study completedNCT03594747
What this trial is testing

Tislelizumab in Combination With Chemotherapy Versus Chemotherapy in Advanced Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
BeiGene 360
Early research (Phase 1)Study completedNCT01466647
What this trial is testing

The IGF-1R Inhibitor AXL1717 in Combination With Gemcitabine HCL and Carboplatin to Treat Non-small-cell Lung Cancer (NSCLC)

Who this might be right for
Non Small Cell Lung Cancer
Axelar AB 12
Large-scale testing (Phase 3)Ended earlyNCT04746924
What this trial is testing

Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Who this might be right for
Non-small Cell Lung CancerNSCLC
BeiGene 669
Large-scale testing (Phase 3)Active Not RecruitingNCT05973773
What this trial is testing

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

Who this might be right for
Advanced or Metastatic NSCLS With Exon 20 Insertion Mutation
Taiho Oncology, Inc. 285
Next Page